Phase 4 Master Protocol for Patients Prescribed Prademagene Zamikeracel for the Treatment of Wounds

Clinical trial NCT07717736 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07717736
Sponsor: Abeona Therapeutics, Inc
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Epidermolysis Bullosa (EB)Recessive Dystrophic Epidermolysis Bullosa (RDEB)Dystrophic Epidermolysis Bullosa (DEB)

Start date: 2026-11-01
Primary completion: 2031-11-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.